Therapeutics in the Pipeline Targeting <i>&#945;</i>-Synuclein for Parkinson's Disease.

Grosso Jasutkar, Hilary; Oh, Stephanie E; Mouradian, M Maral

Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease.

Grosso Jasutkar, Hilary; Oh, Stephanie E; Mouradian, M Maral.

Afiliação

Grosso Jasutkar H; Robert Wood Johnson Medical School Institute for Neurological Therapeutics, and Department of Neurology, Rutgers Biomedical and Health Sciences, Piscataway, New Jersey.
Oh SE; Robert Wood Johnson Medical School Institute for Neurological Therapeutics, and Department of Neurology, Rutgers Biomedical and Health Sciences, Piscataway, New Jersey.
Mouradian MM; Robert Wood Johnson Medical School Institute for Neurological Therapeutics, and Department of Neurology, Rutgers Biomedical and Health Sciences, Piscataway, New Jersey m.mouradian@rutgers.edu.

Pharmacol Rev ; 74(1): 207-237, 2022 01.

Article em En | MEDLINE | ID: mdl-35017177

Assuntos

Doenças Neurodegenerativas; Doença de Parkinson; Encéfalo/metabolismo; Humanos; Corpos de Lewy/metabolismo; Doença de Parkinson/tratamento farmacológico; alfa-Sinucleína/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Doenças Neurodegenerativas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google